
Celia C Chang
Examiner (ID: 4542, Phone: (571)272-0679 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1202, 2899, 1203, 1625 |
| Total Applications | 3041 |
| Issued Applications | 1838 |
| Pending Applications | 177 |
| Abandoned Applications | 1031 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5023604
[patent_doc_number] => 20070149570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Piperidine derivative and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/701380
[patent_app_country] => US
[patent_app_date] => 2007-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45366
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149570.pdf
[firstpage_image] =>[orig_patent_app_number] => 11701380
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/701380 | Piperidine derivative and use thereof | Feb 1, 2007 | Abandoned |
Array
(
[id] => 4977981
[patent_doc_number] => 20070219214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation'
[patent_app_type] => utility
[patent_app_number] => 11/700788
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27970
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11700788
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/700788 | Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation | Jan 31, 2007 | Abandoned |
Array
(
[id] => 4740832
[patent_doc_number] => 20080234485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => '1-Benzyl-4-[ (5,6-Dimethoxy-1-Indanon) -2-Yl] Methylpiperidine Hydrobromide or Crystals Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/995975
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3418
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234485.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995975
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995975 | 1-Benzyl-4-[ (5,6-Dimethoxy-1-Indanon) -2-Yl] Methylpiperidine Hydrobromide or Crystals Thereof | Jan 31, 2007 | Abandoned |
Array
(
[id] => 5113614
[patent_doc_number] => 20070197530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Amido compounds and their use as pharmaceuticals'
[patent_app_type] => utility
[patent_app_number] => 11/699826
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25625
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197530.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699826
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699826 | Amido compounds and their use as pharmaceuticals | Jan 29, 2007 | Abandoned |
Array
(
[id] => 5070262
[patent_doc_number] => 20070191364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'AMINOPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/626972
[patent_app_country] => US
[patent_app_date] => 2007-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26854
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191364.pdf
[firstpage_image] =>[orig_patent_app_number] => 11626972
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/626972 | AMINOPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | Jan 24, 2007 | Abandoned |
Array
(
[id] => 5023596
[patent_doc_number] => 20070149562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'OXOPIPERIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/626970
[patent_app_country] => US
[patent_app_date] => 2007-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40394
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149562.pdf
[firstpage_image] =>[orig_patent_app_number] => 11626970
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/626970 | OXOPIPERIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Jan 24, 2007 | Abandoned |
Array
(
[id] => 5253318
[patent_doc_number] => 20070134774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'PROCESS FOR THE PRODUCTION OF PIPERIDINE DERIVATIVES WITH MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 11/624096
[patent_app_country] => US
[patent_app_date] => 2007-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6356
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134774.pdf
[firstpage_image] =>[orig_patent_app_number] => 11624096
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/624096 | Process for the production of piperidine derivatives with microorganisms | Jan 16, 2007 | Issued |
Array
(
[id] => 4658241
[patent_doc_number] => 20080027103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Novel Crystalline Forms 1'
[patent_app_type] => utility
[patent_app_number] => 11/622596
[patent_app_country] => US
[patent_app_date] => 2007-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5204
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20080027103.pdf
[firstpage_image] =>[orig_patent_app_number] => 11622596
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/622596 | Novel Crystalline Forms 1 | Jan 11, 2007 | Abandoned |
Array
(
[id] => 4658242
[patent_doc_number] => 20080027104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Novel Crystalline Forms 2'
[patent_app_type] => utility
[patent_app_number] => 11/622606
[patent_app_country] => US
[patent_app_date] => 2007-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5523
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20080027104.pdf
[firstpage_image] =>[orig_patent_app_number] => 11622606
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/622606 | Novel Crystalline Forms 2 | Jan 11, 2007 | Abandoned |
Array
(
[id] => 5005611
[patent_doc_number] => 20070203183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Diaryl piperidines as CB1 modulators'
[patent_app_type] => utility
[patent_app_number] => 11/652227
[patent_app_country] => US
[patent_app_date] => 2007-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48507
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11652227
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/652227 | Diaryl piperidines as CB1 modulators | Jan 10, 2007 | Abandoned |
Array
(
[id] => 4928107
[patent_doc_number] => 20080167470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Process of enantiomeric resolution of D,L-(+_)-threo-methylphenidate'
[patent_app_type] => utility
[patent_app_number] => 11/650278
[patent_app_country] => US
[patent_app_date] => 2007-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4396
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167470.pdf
[firstpage_image] =>[orig_patent_app_number] => 11650278
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/650278 | Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate | Jan 4, 2007 | Issued |
Array
(
[id] => 5070249
[patent_doc_number] => 20070191351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/614044
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 60833
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191351.pdf
[firstpage_image] =>[orig_patent_app_number] => 11614044
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/614044 | Salts of potassium ATP channel openers and uses thereof | Dec 19, 2006 | Issued |
Array
(
[id] => 5063674
[patent_doc_number] => 20070225314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Novel forms of tiotropium bromide and processes for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 11/643001
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12259
[patent_no_of_claims] => 148
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225314.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643001 | Forms of tiotropium bromide and processes for preparation thereof | Dec 18, 2006 | Issued |
Array
(
[id] => 5070329
[patent_doc_number] => 20070191431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => '2-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulation'
[patent_app_type] => utility
[patent_app_number] => 11/640751
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12427
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191431.pdf
[firstpage_image] =>[orig_patent_app_number] => 11640751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/640751 | 2-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulation | Dec 17, 2006 | Abandoned |
Array
(
[id] => 4950145
[patent_doc_number] => 20080306271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Novel Process for Production of Highly Pure Polymorph (I) Donepezil Hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 12/094304
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3903
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306271.pdf
[firstpage_image] =>[orig_patent_app_number] => 12094304
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094304 | Novel Process for Production of Highly Pure Polymorph (I) Donepezil Hydrochloride | Dec 17, 2006 | Abandoned |
Array
(
[id] => 5120674
[patent_doc_number] => 20070142389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'PIPERIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/610696
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21463
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142389.pdf
[firstpage_image] =>[orig_patent_app_number] => 11610696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/610696 | PIPERIDINE DERIVATIVES | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5096238
[patent_doc_number] => 20070117847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'N-(3-(4-Substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/635942
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25841
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117847.pdf
[firstpage_image] =>[orig_patent_app_number] => 11635942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/635942 | N-(3-(4-Substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists | Dec 7, 2006 | Abandoned |
Array
(
[id] => 5220323
[patent_doc_number] => 20070161634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Compounds as CCR5 antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/634808
[patent_app_country] => US
[patent_app_date] => 2006-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13408
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161634.pdf
[firstpage_image] =>[orig_patent_app_number] => 11634808
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/634808 | Compounds as CCR5 antagonists | Dec 5, 2006 | Abandoned |
Array
(
[id] => 5231456
[patent_doc_number] => 20070293564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Dimeric compounds and their use as anti-viral agents'
[patent_app_type] => utility
[patent_app_number] => 11/607872
[patent_app_country] => US
[patent_app_date] => 2006-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9810
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293564.pdf
[firstpage_image] =>[orig_patent_app_number] => 11607872
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/607872 | Dimeric compounds and their use as anti-viral agents | Dec 3, 2006 | Abandoned |
Array
(
[id] => 4792795
[patent_doc_number] => 20080293769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Polymorphs of a C-Met/Hgfr Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/095116
[patent_app_country] => US
[patent_app_date] => 2006-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5644
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293769.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095116
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095116 | Polymorphs of a c-MET/HGFR inhibitor | Nov 22, 2006 | Issued |